If you aren’t meaningfully engaged with the IDR process or your health system has been navigating Independent Dispute Resolution (IDR) reactively by submitting disputes when volumes spike, tracking outcomes in spreadsheets, outsourcing IDR to a law firm or treating IDR as a back-office billing function, the cost of that approach will compound significantly in 2026.

The IDR landscape has fundamentally shifted. Federal agencies have issued new guidance, arbitrator pools have expanded, and payors have grown more sophisticated in their dispute defense strategies. Health systems that build a structured, proactive hospital IDR strategy in 2026 will recover meaningfully more eligible revenue. Those that don't will continue leaving millions on the table and take on avoidable compliance risk in the process.

If you are a health system VP, CRO or CFO who is responsible for the financial performance of your organizations and needs a clear-eyed view of what IDR planning looks like in the year ahead, read on.

Why IDR Can No Longer Be an Afterthought

The No Surprises Act (NSA), which took effect in January 2022, fundamentally changed how out-of-network payment disputes are resolved. The federal IDR process replaced balance billing, giving providers and payors a structured mechanism to resolve payment disagreements through certified arbitrators.

What wasn't anticipated by many, was the sheer volume of disputes that would flow through the system. The IDR portal has faced persistent backlogs, administrative delays, and ongoing litigation that has repeatedly reshaped the rules. For health systems, this has created a compounding challenge: the revenue at stake is enormous, but the process for recovering it is complex, time-sensitive, and rapidly evolving.

For a large hospital or multi-site health system, the financial implications are significant. Disputes that go unfiled, improperly filed, or poorly supported can result in arbitrators siding with payors and not because the health system's position was weak, but because the submission wasn't optimized for the evidentiary standards that arbitrators actually apply.

The window to correct the course is now. Health systems that treat IDR as a strategic function and not an administrative one will be positioned to recover more revenue, reduce operational friction, and approach 2026 with a plan rather than a reaction.

The Current IDR Landscape: What's Changed Heading Into 2026

Before building your 2026 strategy, it helps to understand what has actually changed in the IDR environment over the past 12-18 months, including with the recent publication of the Federal IDR Operations Final Rule.

IDR participation is moving upstream from provider groups to health systems. Initially, many of the provider organizations engaging in IDR were those with the most obvious NSA and IDR eligibility — provider groups with some percentage of out-of-network claims generated in an in-network setting. Today, a growing number of the health systems and hospitals in which these providers operate are also engaging directly in the process.

Arbitrator decision patterns have matured. Early in the program's history, arbitrators were still calibrating how to weigh QPA versus other credible information. That learning curve has largely stabilized. Arbitrators now apply more consistent frameworks, which means providers who understand those frameworks and structure their submissions accordingly have a measurable advantage.

Payors have become more engaged in the process. Large payors have invested in IDR operations teams, technology and legal resources dedicated to disputing provider claims at scale. They engage in open negotiation, provide counter-offers, and challenge eligibility at higher rates than they did in 2022 or 2023. Every provider organization’s IDR strategy needs to account for a more engaged counterpart.

The QPA methodology remains contested but core to the process. Ongoing disagreement around how payors calculate the qualifying payment amount has created uncertainty, but it has also created opportunity. Health systems that understand how to challenge QPA calculations and present credible alternative market-based benchmarks are recovering more in arbitration. This is a skill set, not a default.

Batching rules are changing. CMS has updated guidance around when and how disputes can be batched by service category and payor, and when the Federal Operations Rule batching provisions take effect later this year there will be even more changes. Health systems that haven't audited their batching approach in the past year may be leaving efficiency on the table, losing entire batches of claims, or inadvertently triggering eligibility disputes.

Timelines are unforgiving. The 30-business-day open negotiation window and subsequent IDR filing deadlines are hard stops. Missed deadlines mean forfeited disputes and forfeited revenue. At scale, even a 5-10% deadline miss rate can represent millions of dollars annually.

Five Strategic Priorities for Your 2026 Hospital IDR Strategy

Building an effective hospital IDR strategy for 2026 isn't just about filing more disputes. It's about filing smarter disputes, faster, with better documentation and building the organizational infrastructure to sustain that process at scale.

Here are the five priorities every health system should be planning around now.

1. Conduct a Full IDR Revenue and Eligibility Audit

Before you can optimize your IDR program, you need an accurate picture of where you stand. That means answering questions your current billing and RCM systems may not be structured to surface:

• What percentage of your out-of-network claims actually meet NSA eligibility criteria for IDR, and how does that break down across specialties and payor contracts?
• What percentage of eligible IDR disputes is your organization actually filing, and which are being missed?
• What is your current win rate, and how does it compare by specialty, payor, and dispute type?
• Where disputes are being lost and is the common factor submission quality, rate challenges, or eligibility disputes?

For most health systems, this audit surfaces a significant gap between eligible and filed disputes and between filed disputes and recoverable revenue. That gap is your baseline. Your 2026 strategy is built on closing it.

2. Segment Your Dispute Portfolio by Specialty and Risk Profile

Not all IDR disputes are created equal. Emergency medicine, anesthesiology, and radiology, the specialties most commonly affected by out-of-network status, have distinct dispute characteristics, typical claim values, and payor behavior patterns. Treating them as a single population in your IDR workflow is a strategic mistake.

A mature IDR hospital strategy segments dispute portfolios by:

• Specialty - because arbitrators look at specialty-specific benchmarks when evaluating credible information
• Payor - because different payors use different QPA methodologies and have different litigation propensities
• Claim value - because the cost-benefit calculus of pursuing arbitration and laying our IDR fees differs significantly between a $100 claim and a $5,000 one
• Batching eligibility - because grouping disputes by service category and time period can substantially improve operational efficiency
• State - Certain states have their own state-level IDR process, while others defer to the federal process. You can learn more about the state vs. federal IDR process here.

Health systems that segment their portfolios can prioritize high-value disputes, batch appropriately, and tailor their evidentiary approach based on a multitude of success factors.

3. Invest in QPA and Market Rate Analysis Capabilities

The qualifying payment amount is the anchor of every IDR dispute. Payors calculate it based on their median contracted rate for a service in a given geographic area. This calculation is often opaque, difficult to verify, sometimes inaccurate.

Health systems that can rigorously analyze QPA amounts and identify cases where the payor's calculation appears to understate market rates are in a fundamentally stronger position in arbitration. Arbitrators are required to begin with QPA as the presumptive value, but they can and do deviate when providers present credible information demonstrating that a higher amount is appropriate.

Credible information includes your historical contracted rates, market benchmarks like FAIR Health or HCRIS data, the provider’s specific training, experience, and complexity of care. The health systems winning more disputes in 2026 will be those that have invested in the analytical infrastructure to build this case systematically and not case by case.

If your current team is manually pulling this data for every dispute, you will run into a capacity problem. That's where partnering with a capable IDR technology solution becomes a force multiplier rather than a cost center.

4. Build Operational Infrastructure Around IDR Timelines

One of the most common and most preventable sources of IDR revenue leakage is missed deadlines. The 30-business-day open negotiation window is strict, and actively tracking which claims are in that cooling-off period, including when each one expires, is an operational challenge in itself. The subsequent IDR filing window is equally strict. Requests for additional information from the IDR portal have response deadlines. Eligibility dispute responses have deadlines.

At the scale of a large health system, tracking these timelines manually or within a general-purpose RCM system is a recipe for missed revenue. Your 2026 planning should include a clear answer to: what system of record owns IDR timeline tracking, and who is accountable for ensuring nothing ages out?

This is often where health systems discover that IDR has been owned diffusely (part billing, part compliance, part contracting) with no single function accountable for performance. Consolidating ownership and establishing clear SLAs around dispute initiation, submission quality review, deadline management, and outcomes is foundational to scaling your program.

5. Establish a Performance Measurement Framework

IDR is a revenue recovery function, and it should be measured like one. If you're not tracking the following metrics on at least a monthly basis, you don't have full visibility into program performance:

• Arbitration win rate - by specialty, payor, and dispute type
• Average recovery per dispute - relative to claim value and QPA
• Time to determination - While many portions of the IDR process cannot be accelerated, a strong IDR process can accelerate time to determination
• Administrative cost per dispute - to calculate true net recovery

These metrics tell you where your program is performing, where it's leaking, and what to prioritize. They also give you the data you need to have productive conversations with your CFO, your RCM leadership, and any external IDR partners about where investment will generate the highest return.

The Case for Partnering with a Specialized IDR Healthcare Company

Health systems face a genuine build-vs-buy decision when it comes to IDR program sophistication. Building internal expertise in QPA and market rate analysis, arbitrator behavior patterns, CMS regulatory updates, and dispute management technology is possible. However, it takes time, significant headcount, and sustained investment, and even well-resourced teams struggle to scale that expertise across high dispute volumes while staying current with regulatory changes.

For many health systems, the more efficient path is partnering with a specialized IDR company that brings pre-built infrastructure, regulatory expertise, and a track record of arbitration outcomes. The right partner doesn't replace your billing team. They augment it with technology purpose-built for what IDR actually demands at scale: the ability to process disputes consistently and at volume, maintain compliance as CMS guidance evolves, and drive measurable improvements in win rates and reimbursement recovery.

When evaluating partners, the questions that matter most to health system VPs, CROs, and CFOs aren't about features but rather outcomes. What is the partner's documented win rate? How do they handle IDRE selection? How do they tailor strategy by payor? How do they formulate a sophisticated IDR position statement? What does their technology do that your current RCM system doesn't, specifically around scalability, compliance automation, and submission effectiveness? How do they stay current with regulatory changes, and how quickly do those changes get reflected in submission strategy?

The answers to those questions separate vendors from strategic partners.

Start With Clarity on Where You Stand

The health systems that will be in the strongest IDR position by the end of 2026 are the ones that start the planning process now, before regulatory changes accelerate, and before payors widen the gap between their sophistication and yours.

That planning starts with an honest assessment of your current program: what you're filing, what you're winning, and where you're leaving revenue on the table.

If you haven't done that assessment recently, or at all, it's the highest-leverage first step you can take.

Ready to understand what your health system's IDR program could be recovering? Our team will analyze your dispute eligibility, filing patterns, and win rates to give you a clear picture of your IDR opportunity and what it would take to capture it. No commitment required.

Let's talk.

‍